Bruce Webber

1.1k total citations
28 papers, 822 citations indexed

About

Bruce Webber is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bruce Webber has authored 28 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 21 papers in Cardiology and Cardiovascular Medicine and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bruce Webber's work include Coronary Interventions and Diagnostics (22 papers), Cardiac Imaging and Diagnostics (13 papers) and Acute Myocardial Infarction Research (10 papers). Bruce Webber is often cited by papers focused on Coronary Interventions and Diagnostics (22 papers), Cardiac Imaging and Diagnostics (13 papers) and Acute Myocardial Infarction Research (10 papers). Bruce Webber collaborates with scholars based in New Zealand, Australia and Denmark. Bruce Webber's co-authors include John A. Ormiston, Mark Webster, Peter Ruygrok, Harvey D. White, Jonathon White, Olivier Darremont, R. M. L. Whitlock, James T. Stewart, John K. French and A Roche and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Bruce Webber

28 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Webber New Zealand 15 742 483 302 289 58 28 822
Shimpei Nakatani Netherlands 16 821 1.1× 503 1.0× 307 1.0× 376 1.3× 17 0.3× 52 903
Mark S. Patterson Netherlands 15 633 0.9× 495 1.0× 339 1.1× 196 0.7× 26 0.4× 45 799
Yasushi Fuku Japan 15 473 0.6× 395 0.8× 215 0.7× 183 0.6× 27 0.5× 84 599
Paul Zalesky United States 5 453 0.6× 233 0.5× 353 1.2× 186 0.6× 16 0.3× 11 581
Adam Cannon United States 10 605 0.8× 447 0.9× 288 1.0× 250 0.9× 56 1.0× 15 721
Jason Foerst United States 9 470 0.6× 450 0.9× 145 0.5× 171 0.6× 14 0.2× 30 675
Liefke C. van der Heijden Netherlands 15 941 1.3× 775 1.6× 499 1.7× 241 0.8× 41 0.7× 31 1.1k
Brian Bigelow United States 6 372 0.5× 304 0.6× 116 0.4× 116 0.4× 17 0.3× 11 451
Constantine J. Tatooles United States 15 435 0.6× 279 0.6× 90 0.3× 316 1.1× 36 0.6× 31 771
Stefan Windecker Netherlands 9 450 0.6× 545 1.1× 202 0.7× 323 1.1× 6 0.1× 13 792

Countries citing papers authored by Bruce Webber

Since Specialization
Citations

This map shows the geographic impact of Bruce Webber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Webber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Webber more than expected).

Fields of papers citing papers by Bruce Webber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Webber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Webber. The network helps show where Bruce Webber may publish in the future.

Co-authorship network of co-authors of Bruce Webber

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Webber. A scholar is included among the top collaborators of Bruce Webber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Webber. Bruce Webber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webber, Bruce, et al.. (2019). Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent. Catheterization and Cardiovascular Interventions. 96(7). E674–E682. 22 indexed citations
2.
Ormiston, John A., et al.. (2017). Coronary balloon catheter tip damage. A bench study of a clinical problem. Catheterization and Cardiovascular Interventions. 92(5). 883–889. 2 indexed citations
3.
Ormiston, John A., Olivier Darremont, Kiyotaka Iwasaki, et al.. (2015). Lessons from the real bench: non-BRS. EuroIntervention. 11(V). V27–V30. 6 indexed citations
4.
5.
Ormiston, John A., Pascal Motreff, Olivier Darremont, et al.. (2015). Bioresorbable scaffolds on the bench. EuroIntervention. 11(V). V166–V169. 10 indexed citations
6.
7.
Ormiston, John A., et al.. (2015). Coronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend test. EuroIntervention. 10(12). 1449–1455. 24 indexed citations
8.
White, Jonathon, et al.. (2013). TCT-423 Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold. A Bench Study. Journal of the American College of Cardiology. 62(18). B131–B131. 1 indexed citations
9.
Ormiston, John A., Bruce Webber, & Mark Webster. (2011). Stent Longitudinal Integrity. JACC: Cardiovascular Interventions. 4(12). 1310–1317. 138 indexed citations
10.
Ormiston, John A., et al.. (2008). The “Crush” Technique for Coronary Artery Bifurcation Stenting: Insights From Micro-Computed Tomographic Imaging of Bench Deployments. JACC: Cardiovascular Interventions. 1(4). 351–357. 89 indexed citations
11.
French, J., Marc A. Brouwer, John Elliott, et al.. (2006). Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction. American Heart Journal. 153(1). 66.e1–66.e8. 5 indexed citations
12.
Merry, Alan, et al.. (2004). Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. The Annals of Thoracic Surgery. 77(3). 925–931. 78 indexed citations
13.
Ruygrok, Peter, Bruce Webber, Steven Faddy, David W.M. Muller, & Anne Keogh. (2003). Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression. The Journal of Heart and Lung Transplantation. 22(11). 1276–1279. 30 indexed citations
14.
Ormiston, John A., Mark Webster, Peter Ruygrok, et al.. (2002). Six-month angiographic and 12-month clinical follow-up of MultiLink long (25 to 35 mm) stents for long coronary narrowings in patients with angina pectoris. The American Journal of Cardiology. 90(3). 222–226. 6 indexed citations
15.
French, John K., T.A. Hyde, Jacqueline Andrews, et al.. (2000). Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. Journal of the American College of Cardiology. 35(6). 1516–1524. 29 indexed citations
16.
French, John K., T.A. Hyde, Hitesh Patel, et al.. (1999). Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks. Journal of the American College of Cardiology. 34(1). 62–69. 26 indexed citations
17.
18.
Ormiston, John A., et al.. (1996). Late regression of the dilated lesion after coronary angioplasty: A 5 year quantitative angiographic study. Journal of the American College of Cardiology. 27(2). 390–390. 1 indexed citations
19.
Agnew, T. M., Peter W.T. Brandt, J. French, et al.. (1992). The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts. Australian and New Zealand Journal of Medicine. 22(6). 665–670. 14 indexed citations
20.
Agnew, T. M., Peter W.T. Brandt, J. French, et al.. (1992). The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts. Internal Medicine Journal. 22(6). 665–670. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shimpei Nakatani Breakdown of academic impact, for papers by Mark S. Patterson Breakdown of academic impact, for papers by Yasushi Fuku Breakdown of academic impact, for papers by Paul Zalesky Breakdown of academic impact, for papers by Adam Cannon Breakdown of academic impact, for papers by Jason Foerst Breakdown of academic impact, for papers by Liefke C. van der Heijden Breakdown of academic impact, for papers by Brian Bigelow Breakdown of academic impact, for papers by Constantine J. Tatooles Breakdown of academic impact, for papers by Stefan Windecker
Rankless by CCL
2026